LOXL2 and neoplasm: In summary, we show that tumor cell LOXL2 targets proximal mesenchymal fibrogenic cells by a novel microenvironment tumor-promoting mechanism, while small molecule LOXL2 inhibition can improve oral cancer outcomes.